drugset / Trial / NCT00131495

Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido

NCT00131495

Phase 3 Completed 814 enrolled Warner Chilcott
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is designed to evaluate the efficacy and safety of 2 doses of the transdermal testosterone patch in naturally or surgically menopausal women with low libido who are not receiving systemic estrogen or estrogen progestin therapy.

Timeline

Start
2004-07
Primary completion
2006-02
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 150 ug Other
Subject Testosterone Small molecule 300 ug Other